Submitted:
19 August 2025
Posted:
20 August 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Material and Methods
2.1. Participants
2.2. Procedure
2.3. Data Analysis
2.4. Statistical Analysis
3. Results
Regression Analysis
4. Discussion
4.1. Maximal Values During GXT
4.2. Slope Values at Bsln+1.0 and OBLA4
4.3. Correlations Between External and Internal Variables
4.4. Effect of Hypoxia Under External Load Thresholds Variables
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
Abbreviations
| ANOVA: analysis of variance |
| bpm: beats per minute |
| Bsln+1.0: 1 mmol/L above the lowest lactate value |
| CI: confidence intervals |
| CINR: international federation competition ranking |
| d: Cohen’s d effect size |
| FiO₂: fraction of Inspired Oxygen |
| GE: gross efficiency |
| GXT: the graded exercise test |
| m.a.s.l.: meters above sea level |
| OBLA4: Onset Blood Lactate Accumulation of 4 mmol/L |
| p: probabilistic values |
| PosCS: after competitive period |
| PreCs: prior competitive period |
| SD: standard deviation |
| VO₂: oxygen consumption |
| VO₂max: maximum oxygen consumption |
| VO₂peak: peak oxygen |
| XC: cross-country skiing |
| 15kmSwedNat: national swedish championships |
References
- Carlsson, M., Carlsson, T., Hammarström, D., Tiivel, T., Malm, C., & Tonkonogi, M. (2012). Validation of physiological tests in relation to competitive performances in elite male distance cross-country skiing. J Strength Cond Res, 26(6), 1496–1504. [CrossRef]
- Chapman, R. F., Laymon, A. S., & Levine, B. D. (2013). Timing of arrival and pre-acclimatization strategies for the endurance athlete competing at moderate to high altitudes. High Altitude Medicine and Biology, 14(4). [CrossRef]
- Clark, S. A., Bourdon, P. C., Schmidt, W., Singh, B., Cable, G., Onus, K. J., Woolford, S. M., Stanef, T., Gore, C. J., & Aughey, R. J. (2007). The effect of acute simulated moderate altitude on power, performance and pacing strategies in well-trained cyclists. Eur J Appl Physiol, 102(1), 45–55. [CrossRef]
- Cohen, J. (1988). Statistical power analysis for the behavioural sciences. Hillside. In NJ: Lawrence Earlbaum Associates. Lawrence Erlbaum Associates, Publishers.
- Dufour, S. P., Ponsot, E., Zoll, J., Doutreleau, S., Lonsdorfer-Wolf, E., Geny, B., Lampert, E., Flück, M., Hoppeler, H., Billat, V., Mettauer, B., Richard, R., & Lonsdorfer, J. (2006). Exercise training in normobaric hypoxia in endurance runners. I. Improvement in aerobic performance capacity. Journal of Applied Physiology, 100(4). [CrossRef]
- Fabre, N., Balestreri, F., Pellegrini, B., & Schena, F. (2010). The modified DMax method is reliable to predict the second ventilatory threshold in elite cross-country skiers. J Strength Cond Res., 24(6), 1546–1552. [CrossRef]
- Fabre, N., Bortolan, L., Pellegrini, B., Zerbini, L., Mourot, L., & Schena, F. (2012). Anaerobic threshold assessment through the ventilatory method during roller-ski skating testing: Right or wrong? Journal of Strength and Conditioning Research, 26(2). [CrossRef]
- Faiss, R., Von Orelli, C., Dériaz, O., & Millet, G. P. (2014). Responses to exercise in normobaric hypoxia: Comparison of elite and recreational ski mountaineers. International Journal of Sports Physiology and Performance, 9(6), 978–984. [CrossRef]
- Fulco, C. S., Rock, P. B., & Cymerman, A. (1998). Maximal and submaximal exercise performance at altitude. In Aviation Space and Environmental Medicine (Vol. 69, Issue 8).
- Ingjer, F. (1991). Maximal oxygen uptake as a predictor of performance ability in women and men elite cross-country skiers. Scand J Med Sci Sports., 1(1), 25–30. [CrossRef]
- Jakobsson, J., & Malm, C. (2019). Maximal Lactate Steady State and Lactate Thresholds in the Cross-Country Skiing Sub-Technique Double Poling. Int J Exerc Sci., 12(2), 57–68.
- Larsson, P., Olofsson, P., Jakobsson, E., Burlin, L., & Henriksson-Larsén, K. (2002). Physiological predictors of performance in cross-country skiing from treadmill tests in male and female subjects. Scand J Med Sci Sports., 12(6), 347–353. [CrossRef]
- Losnegard, T., & Hallén, J. (2014). Elite cross-country skiers do not reach their running VO2max during roller ski skating. Journal of Sports Medicine and Physical Fitness, 54(4).
- Meeusen, R., Duclos, M., Foster, C., Fry, A., Gleeson, M., Nieman, D., Raglin, J., Rietjens, G., Steinacker, J., & Urhausen, A. (2013). Prevention, diagnosis, and treatment of the overtraining syndrome: Joint consensus statement of the european college of sport science and the American College of Sports Medicine. Medicine and Science in Sports and Exercise, 45(1). [CrossRef]
- Mourot, L. (2018). Limitation of Maximal Heart Rate in Hypoxia: Mechanisms and Clinical Importance. Frontiers in Physiology, 9(JUL). [CrossRef]
- Pfitzinger, P., & Freedson, P. S. (1998). The reliability of lactate measurements during exercise. Int J Sports Med, 19(5), 349–357. [CrossRef]
- Raa, A., Sunde, G. A., Bolann, B., Kvåle, R., Bjerkvig, C., Eliassen, H. S., Wentzel-Larsen, T., & Heltne, J. K. (2020). Validation of a point-of-care capillary lactate measuring device (Lactate Pro 2). Scand J Trauma Resusc Emerg Med., 28(1), 83. [CrossRef]
- Roels, B., Bentley, D. J., Coste, O., Mercier, J., & Millet, G. P. (2007). Effects of intermittent hypoxic training on cycling performance in well-trained athletes. European Journal of Applied Physiology, 101(3). [CrossRef]
- Sandbakk, Ø., & Holmberg, H. C. (2017). Physiological capacity and training routines of elite cross-country skiers: Approaching the upper limits of human endurance. In Int J Sports Physiol Perform. (Vol. 12, Issue 8, pp. 1003–1011). [CrossRef]
- Sandbakk, Ø., Holmberg, H. C., Leirdal, S., & Ettema, G. (2010). Metabolic rate and gross efficiency at high work rates in world class and national level sprint skiers. Eur J Appl Physiol., 109(3), 473–481. [CrossRef]
- Schüttler, D., Weckbach, L. T., Hamm, W., Maier, F., Kassem, S., Schier, J., Lackermair, K., & Brunner, S. (2021). Effect of acute altitude exposure on ventilatory thresholds in recreational athletes. Respir Physiol Neurobiol., 293:103723(.). [CrossRef]
- Shang, L., Sandbakk, Ø., Shi, R., Chen, X., & Talsnes, R. K. (2022). Analysis of a Skating Time-Trial Competition and Associated Performance-Determinants in Cross-Country Skiers. Int J Environ Res Public Health., 19(18), 11580. [CrossRef]
- Sharma, A. P., Saunders, P. U., Garvican-Lewis, L. A., Clark, B., Gore, C. J., Thompson, K. G., & Périard, J. D. (2019). Normobaric Hypoxia Reduces VO2 at Different Intensities in Highly Trained Runners. Med Sci Sports Exerc., 51(1), 174–182. [CrossRef]
- Sollie, O., & Losnegard, T. (2022). Anthropometrical and Physiological Determinants of Laboratory and on-Snow Performance in Competitive Adolescent Cross-Country Skiers. Front Physiol., 13:819979. [CrossRef]
- Stöggl, R., Müller, E., & Stöggl, T. (2023). Technique and maximal skiing speed for youth cross-country skiing performance. Front Sports Act Living., 5:1133777. [CrossRef]
- Urhausen, A., & Kindermann, W. (2002). Diagnosis of overtraining: What tools do we have? In Sports Medicine (Vol. 32, Issue 2). [CrossRef]
- Wehrlin, J. P., & Hallén, J. (2006). Linear decrease in VO2max and performance with increasing altitude in endurance athletes. Eur J Appl Physiol., 96(4), 404–412. [CrossRef]

| Variable | PreCS | PosCs | Result between PreCs and PosCs |
Normoxia Vs. Hypoxia in PreCs |
Normoxia Vs. Hypoxia in PosCs |
|
|---|---|---|---|---|---|---|
| Mean ± Standard Deviation |
Mean ± Standard Deviation |
Wilcoxon´s test values | p d |
p d |
||
| HYPOXIA |
Maximum Lactate (mmol/L) |
8.6 ± 2.7 |
7.1 ± 2.2 # |
p= 0.011,difference = 1.48, 95% CI [0.61, 2.35], d = 1.11, 95% CI [-0.51, 2.84], large |
p = 0.144, difference = 0.88, 95% CI [-0.37, 2.13], d = 0.54, 95% CI [-0.18, 1.23], medium |
p = 0.803, difference = 0.20, 95% CI [-1.59, 1.99], d = 0.09, 95% CI [-0.57, 0.74], small |
|
Maximum Heart Rate (bpm) |
195 ± 8.1 | 191 ± 9.1 # |
p= 0.012,difference = 4.11, 95% CI [2.08, 6.13], d = 1.32, 95% CI [-0.73, 2.86], large |
p = 0.657, difference = 0.56, 95% CI [-2.22, 3.33], d = 0.15, 95% CI [-0.51, 0.81], small |
p = 0.427, difference = -1.11, 95% CI [-4.17, 1.95], d = -0.28, 95% CI [-0.94, 0.40], small | |
|
Maximum Slope (%) |
10 ± 2.0 | 9.2 ± 1.3 |
p= 0.057,difference = 0.91, 95% CI [0.29, 1.52], d = 0.96, 95% CI [-0.48, 1.96], large |
p = 0.896, difference = 0.04, 95% CI [-0.72, 0.80], d = 0.04, 95% CI [-0.61, 0.70], small |
p > .999, difference = 0.00, 95% CI [-0.70, 0.70], d = 0.00, 95% CI [-0.65, 0.65], small |
|
| NORMOXIA |
Maximum Lactate (mmol/L) |
7.7 ± 2.2 |
6.9 ± 3.4 # |
p= 0.028,difference = 0.81, 95% CI [-0.47, 2.09], d = 0.41, 95% CI [-0.20, 1.57], small |
||
|
Maximum Heart Rate (bpm) |
195 ± 9.3 | 192 ± 9.4 |
p= 0.105,difference = 2.44, 95% CI [0.06, 4.82], d = 0.67, 95% CI [-0.12, 1.51], medium |
|||
|
Maximum Slope (%) |
10 ± 1.8 | 9.2 ± 1.7 |
p= 0.091,difference = 0.86, 95% CI [0.24, 1.49], d = 0.90, 95% CI [-0.19, 2.92], large |
|||
| Variable | PreCS | PosCs | Result between PreCs and PosCs | Normoxia Vs. Hypoxia in PreCs |
Normoxia Vs. Hypoxia in PosCs |
|
|---|---|---|---|---|---|---|
| Mean ± Standard Deviation |
Mean ± Standard Deviation |
Wilcoxon´s test values | P d |
P d |
||
|
HYPOXIA Bsln+1.0 |
Lactate (mmol/L) |
2.5 ± 0.24 | 2.5 ± 0.25 |
p= 0.550, difference =0.03, 95% CI [-0.06,0.13], d =0.21, 95% CI [-1.05,0.84] small |
p = 0.053, difference = 0.10, 95% CI [-1.69e-03, 0.20], d = 0.76, 95% CI [-9.59e-03, 1.49], medium |
p = 0.111, difference = 0.13, 95% CI [-0.04, 0.31], d = 0.60, 95% CI [-0.13, 1.29], medium |
|
Heart Rate (bpm) |
159 ± 15 | 164 ± 10 |
p= 0.406, difference =4.66, 95% CI [-3.64,12.97], d =0.36, 95% CI [-0.30,1.16] small |
p = 0.197, difference = -5.67, 95% CI [-14.95, 3.62], d = -0.47, 95% CI [-1.15, 0.24], small |
p = 0.325, difference = -3.11, 95% CI [-9.96, 3.74], d = -0.35, 95% CI [-1.01, 0.34], small |
|
|
Slope (%) |
4.5 ± 2.0 * |
5.1 ± 1.2 |
p= 0.250, difference =0.63, 95% CI [-1.04,2.31], d =0.24, 95% CI [-0.32,1.41] small |
p = 0.005, difference = -1.26, 95% CI [-2.00, -0.51], d = -1.29, 95% CI [-2.17, -0.3], large |
p = 0.165, difference = -0.44, 95% CI [-1.11, 0.22], d = -0.51, 95% CI [-1.19, 0.20], medium |
|
|
HYPOXIA OBLA4 |
Heart Rate (bpm) |
178 ± 16 | 179 ± 12 | p= 0.440, difference =0.66, 95% CI [-4.85,6.19], d =0.07, 95% CI [-0.47,1.60] |
p = 0.111, difference = -4.44, 95% CI [-10.17, 1.28], d = -0.60, 95% CI [-1.29, 0.13], medium |
p = 0.056, difference = -4.11, 95% CI [-8.36, 0.14], d = -0.74, 95% CI [-1.47, 0.02], medium |
|
Slope (%) |
6.7 ± 1.8 * |
6.9 ± 1.3 * |
p= 0.496, difference =0.13, 95% CI [-0.29,1.56], d =0.06, 95% CI [-0.46,1.29] |
p = 0.013, difference = -0.85, 95% CI [-1.47, -0.24], d = -1.06, 95% Cl [-1.87, -0.21], large |
p= 0.02, difference = -0.44, 95% CI [-0.79, -0.08], d= -0.95, 95% CI [-1.73, -0.13], large |
|
|
NORMOXIA Bsln+1.0 |
Lactate (mmol/L) |
2.4 ± 0.19 | 2.4 ± 0.19 |
p= 0.714, difference =0, 95% CI [-0.11,0.11], d =-2.73, 95% CI [-1.16,0.54] small |
||
|
Heart Rate (bpm) |
165 ± 16 | 167 ± 17 |
p= 0.341, difference =2.11, 95% CI [-5.93,10.15], d =0.17, 95% CI [-0.42,1.98] |
|||
|
Slope (%) |
5.7 ±1.8 | 5.5 ± 1.6 |
p= 0.652, difference =-0.17, 95% CI [-1.76,1.40], d =-0.07, 95% CI [-0.56,1.24] |
|||
|
NORMOXIA OBLA4 |
Heart Rate (bpm) |
183 ± 19 | 183 ± 16 | p= 0.635, difference =-0.33, 95% CI [-5.36,6.02], d =-0.03, 95% CI [-0.62,1.03] small |
||
|
Slope (%) |
7.6 ± 1.7 | 7.3 ± 1.6 | p= 0.734, difference =-0.27, 95% CI [-1.68,1.13], d =-0.12, 95% CI [-0.59,0.98] |
|||
| Variable | ∆ between Hypoxia Vs. Normoxia PreCs |
∆ between Hypoxia Vs. Normoxia PosCs |
Wilcoxon test results between ∆ PreCs vs PosCs |
|---|---|---|---|
| Slope at Bsln+1.0 (%) |
-1.25±0.97* | -0.44 ± 0.86 | p = 0.020; 95% CI [-0.97, -0.53] |
| Slope at OBLA 4 (%) |
-0.85 ± 0.80 | -0.43 ± 0.46 | p = 0.098; 95% CI [-0.91, -0.03] |
Author’s Biography
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).